References
- Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. Int J Molec Sci. 2021;22(16):10. DOI: 10.3390/ijms22168661
- Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US. JAMA oncol. 2021;7(12):1824-32. DOI: 10.1001/jamaoncol.2021.4932
- Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet (London, England). 2016;388(10055):2023-38. DOI: 10.1016/S0140-6736(16)30173-8
- Lin YJ, Anzaghe M, Schülke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020;9(4):10. DOI: 10.3390/cells9040880
- Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert rev clin immunol. 2022;18(9):923-31. DOI: 10.1080/1744666X.2022.2106970
- Rubbert-Roth A, Zander T, Kneitz C, Baerwald C, Wirtz H, Witt C. [Lung cancer and rheumatoid arthritis. An interdisciplinary challenge]. Zeitschrift fur Rheumatologie. 2016;75(1):47-53. DOI: 10.1007/s00393-016-0043-0
- Wu X, Peng H, Wen Y, Cai X, Li C, Zhong R, et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. Sem arthr rheum. 2021;51(3):565-75. DOI: 10.1016/j.semarthrit.2021.03.015
- Fragoulis GE, Chatzidionysiou K. Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening? Clin rheum. 2020;39(3):957-61. DOI: 10.1007/s10067-019-04882-x
- Zhao W, Langfelder P, Fuller T, Dong J, Li A, Hovarth S. Weighted gene coexpression network analysis: state of the art. J Biopharm stat. 2010;20(2):281-300. DOI: 10.1080/10543400903572753
- Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008;9:559. DOI: 10.1186/1471-2105-9-559
- Rhoads A, Au KF. PacBio Sequencing and Its Applications. Genomics, proteomics & bioinformatics. 2015;13(5):278-89. DOI: 10.1016/j.gpb.2015.08.002
- Zhang J, Li Y, Yang Y, Huang J, Sun Y, Zhang X, et al. A novel iTreg-related signature for prognostic prediction in lung adenocarcinoma. Cancer sci. 2023. DOI: 10.1111/cas.16015
- Viktorsson K, Hååg P, Shah CH, Franzén B, Arapi V, Holmsten K, et al. Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome. Molec oncol. 2022;16(20):3620-41. DOI: 10.1002/1878-0261.13288
- Liu Y, Fan S, Meng S. Identification of the candidate genes of diagnosing rheumatoid arthritis using the single-cell sequencing technology and T cell subclusters analysis of patients with rheumatoid arthritis. Archiv rheumatol. 2023;38(1):109-18. DOI: 10.46497/ArchRheumatol.2022.9573
- Zhu N, Yang Y, Wang H, Tang P, Zhang H, Sun H, et al. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma. Front Oncol. 2022;12:822849. DOI: 10.3389/fonc.2022.822849
- Fan C, Hu H, Shen Y, Wang Q, Mao Y, Ye B, et al. PRF1 is a prognostic marker and correlated with immune infiltration in head and neck squamous cell carcinoma. Translational oncol. 2021;14(4):101042. DOI: 10.1016/j.tranon.2021.101042
- Zhao Z, Ren J, Xie S, Zou L, Zhao Q, Zeng S, et al. Identification of biomarkers associated with CD8+ T cells in rheumatoid arthritis and their pan-cancer analysis. Front immunol. 2022;13:1044909. DOI: 10.3389/fimmu.2022.1044909
- Mukherjee A, Epperly MW, Fisher R, Hou W, Shields D, Saiful Huq M, et al. Inhibition of tyrosine kinase Fgr prevents radiation-induced pulmonary fibrosis (RIPF). Cell death discovery. 2023;9(1):252. DOI: 10.1038/s41420-023-01538-3
- Lu T, Xu R, Wang C, Zhou X, Parra-Medina R, Díaz-Peña R, et al. Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma. J thoracic disease. 2023;15(7):3885-907. DOI: 10.21037/jtd-23-795
- Schioppa T, Sozio F, Barbazza I, Scutera S, Bosisio D, Sozzani S, et al. Molecular Basis for CCRL2 Regulation of Leukocyte Migration. Front cell develop biol. 2020;8:615031. DOI: 10.3389/fcell.2020.615031
- Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, et al. The Atypical Receptor CCRL2 Is Essential for Lung Cancer Immune Surveillance. Cancer immunol res. 2019;7(11):1775-88. DOI: 10.1158/2326-6066.CIR-19-0168
- Sozio F, Schioppa T, Laffranchi M, Salvi V, Tamassia N, Bianchetto-Aguilera FM, et al. CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer. Cancer immunol res. 2023;11(9):1280-95. DOI: 10.1158/2326-6066.CIR-22-0951
- Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, Alali GH, et al. Overview of Methotrexate Toxicity: A Comprehensive Literature Review. Cureus. 2022;14(9):e29518. DOI: 10.7759/cureus.29518
- Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review. Eur J med chem. 2018;158:502-16. DOI: 10.1016/j.ejmech.2018.09.027
- Xie M, Chen X, Qin S, Bao Y, Bu K, Lu Y. Clinical study on thalidomide combined with cinobufagin to treat lung cancer cachexia. J cancer res therap. 2018;14(1):226-32. DOI: 10.4103/0973-1482.188436
- Dsouza NN, Alampady V, Baby K, Maity S, Byregowda BH, Nayak Y. Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. Inflammopharmacology. 2023;31(3):1167-82. DOI: 10.1007/s10787-023-01193-1